| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc | General Counsel | Ordinary Shares | 0 | $0 | $106.71 | Oct 7, 2025 | Direct |
| Verona Pharma plc | General Counsel | Restricted Share Units | 167K | Jul 7, 2025 | Direct | ||
| Verona Pharma plc | General Counsel | Restricted Stock Units | 146K | Aug 1, 2025 | Direct | ||
| Verona Pharma plc | General Counsel | Restricted Share Unit | 0 | Oct 7, 2025 | Direct | ||
| Verona Pharma plc | General Counsel | Share Options (Right to Buy) | 0 | Oct 7, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VRNA | Verona Pharma plc | Oct 7, 2025 | 8 | $0 | 4 | Oct 8, 2025 | General Counsel |
| VRNA | Verona Pharma plc | Aug 1, 2025 | 3 | -$126K | 4 | Aug 5, 2025 | General Counsel |
| VRNA | Verona Pharma plc | Jul 7, 2025 | 4 | -$452K | 4 | Jul 9, 2025 | General Counsel |
| VRNA | Verona Pharma plc | Jun 16, 2025 | 3 | -$761K | 4 | Jun 18, 2025 | General Counsel |
| VRNA | Verona Pharma plc | May 15, 2025 | 2 | $161K | 4/A | Jun 18, 2025 | General Counsel |
| VRNA | Verona Pharma plc | Mar 19, 2025 | 5 | -$234K | 4 | May 1, 2025 | General Counsel |
| VRNA | Verona Pharma plc | Oct 30, 2024 | 1 | $0 | 4 | Nov 1, 2024 | General Counsel |
| VRNA | Verona Pharma plc | Apr 1, 2024 | 1 | $0 | 4 | Apr 2, 2024 | General Counsel |
| VRNA | Verona Pharma plc | Mar 4, 2024 | 0 | $0 | 3 | Mar 7, 2024 | General Counsel |